ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 399,01
-0,77%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Magenta Therapeutics Inc (MGTA)

  7. Magenta Therapeutics Inc (MGTA) Actualités

MGTA Magenta Therapeutics Inc

11,1936
0,00 (0,00%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Magenta Therapeutics Inc MGTA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 11,1936 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
11,1936 11,1936
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
11/4/202422:10EDGAR2Form ARS - Annual Report to Security Holders
11/4/202422:09EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/4/202422:05EDGAR2Form DEF 14A - Other definitive proxy statements
02/4/202400:34EDGAR2Form SC 13D/A - General statement of acquisition of..
02/4/202400:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/3/202422:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
21/3/202422:02EDGAR2Form S-1/A - General form for registration of securities..
21/3/202421:07EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21/3/202421:04EDGAR2Form 8-K - Current report
14/2/202422:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202422:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202422:52EDGAR2Form S-1/A - General form for registration of securities..
02/2/202422:32EDGAR2Form SC 13G - Statement of acquisition of beneficial..
31/1/202418:11EDGAR2Form SC 13D - General statement of acquisition of beneficial..
26/1/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202400:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202423:26EDGAR2Form SC 13D/A - General statement of acquisition of..
22/1/202413:34EDGAR2Form 8-K - Current report
08/1/202414:02EDGAR2Form 8-K - Current report
21/12/202323:08EDGAR2Form S-1/A - General form for registration of securities..
21/12/202322:16EDGAR2Form 8-K - Current report
09/11/202322:09EDGAR2Form 8-K - Current report
25/10/202322:15EDGAR2Form 8-K - Current report
04/10/202322:55EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/10/202322:20EDGAR2Form S-3 - Registration statement under Securities Act of..
25/9/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202322:34EDGAR2Form SC 13D - General statement of acquisition of beneficial..
21/9/202322:32EDGAR2Form SC 13D - General statement of acquisition of beneficial..
21/9/202322:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
21/9/202322:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
21/9/202303:50EDGAR2Form 8-K/A - Current report: [Amend]
14/9/202303:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202303:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/9/202303:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202303:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202303:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202302:52EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/9/202302:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/9/202302:48EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/9/202302:46EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/9/202302:45EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/9/202322:05EDGAR2Form 8-K - Current report
08/9/202323:19EDGAR2Form 8-K - Current report
31/8/202315:00EDGAR2Form 425 - Prospectuses and communications, business..
03/8/202314:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202322:42EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
17/7/202315:30EDGAR2Form S-4/A - Registration of securities, business..

Dernières Valeurs Consultées

NASDAQ
MGTA
Magenta Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés